Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions
- Status
- COMPLETED
- Phase
- NA
Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC
- Status
- COMPLETED
- Phase
- PHASE2
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC
- Status
- UNKNOWN
- Phase
- N/A
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation
- Status
- UNKNOWN
- Phase
- N/A
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.
- Status
- UNKNOWN
- Phase
- N/A
Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence
- Status
- COMPLETED
- Phase
- NA
Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
- Status
- TERMINATED
- Phase
- PHASE1
Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Influence of Probiotics Administration Before Liver Resection in Liver Disease
- Status
- COMPLETED
- Phase
- NA
Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Laparoscope Anatomical and Aon-anatomical Hepatectomy
- Status
- UNKNOWN
- Phase
- NA